DNA Medicine Institute Awarded NIH Grant for Emergency Point-of-Care Blood Sensor

CAMBRIDGE, Mass., March 9 /PRNewswire/ -- The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).  The grant is designed to shrink technology found in large hospital hematology analyzers, typically the size of small refrigerators, to a tiny, palm-sized device.  The emergency blood sensor is designed to make these tests readily available under any scenario and easily performed by minimally trained personnel.  Applicable settings include hospitals, emergency rooms, physicians' offices, ambulances, global health clinics, and remote field locations.  The Institute envisions this technology will be integrated into its Universal Blood Sensor platform, which is designed to perform all hospital tests on a handheld, point-of-care device.

"We are pleased that the NIH is supporting our efforts to develop a potentially transformative human diagnostics platform.  The NHLBI understands the human impact of a point-of-care blood sensor that can diagnose acute blood loss, sepsis, and other critical health conditions," said Eugene Y. Chan, M.D., President and Chief Scientific Officer of the DNA Medicine Institute.  "This funding will allow us to further innovations in the point-of-care diagnostics field and speed development of a technology that can be utilized to make a difference for those in need."

About DNA Medicine Institute

The DNA Medicine Institute is a commercial organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation.  Founded by Eugene Y. Chan, M.D., its core beliefs are that successful, innovative commercial products can make a long-lasting impact on patient care.  It currently does research on intuitive medical devices, smartly designed drugs, and powerful research instrumentation.  One of these is the Universal Blood Sensor, a technology designed to perform a full health analysis of a person, anywhere, anytime, and with a single drop of blood.  The DNA Medicine Institute's multi-faceted approach to innovation draws upon diverse fields including medicine, nanotechnology, genomics, biophysics, biochemistry, molecular biology, and advanced engineering.  For more information, visit:  www.dnamedinstitute.com.

SOURCE DNA Medicine Institute

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED